Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

An attempt to evaluate the use of mixed reality in surgically treated pediatric oncology patients.

PMID: 40346298 · 2025

JournalNPJ digital medicine
Year2025
PMID40346298

Abstract

Mixed reality (MR) technology is increasingly used in surgical procedures, particularly in pediatric oncological surgery. The CarnaLife Holo system (MedApp S.A., Poland) converts medical imaging data into interactive 3D holograms for preoperative planning and intraoperative use. This study presents a preliminary evaluation of MR's impact on surgical procedure (SP) duration and hospitalization (H) time. A retrospective analysis of patients treated between 2023 and 2024 compared outcomes of surger

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.